# US 2010/0167311 A1 · Oxidoreductases and Processes Utilising Such Enzymes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167311 A1
- Document ID: US20100167311A1
- Status: Published application
- Kind: A1
- Application number: 12/223,850
- Filed: 2007-02-08
- Published: 2010-07-01
- Earliest claimed: 2006-02-09
- Inventors: Gerard W. Canters; Hein Jakob Wijma; Michael Murphy; Iain Macpherson
- Web page: https://patentgrep.com/patent/US20100167311A1

## CPC

- C12Q 1/005: {involving specific analytes or enzymes (including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence)}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

In Cu-containing nitrite reductase from Alcaligenes faecalis S-6 the axial methionine ligand of the type 1 site was replaced (M150G) to make the copper atom accessible to external ligands that might affect the enzyme's catalytic activity. The type-1 site optical spectrum of M150G (A460/A600=0.71) differs significantly from that of the native nitrite reductase (A460/A600=1.3). The reduction potential of the type-1 site of nitrite reductase M150G (EM=312−5 mV versus hydrogen) is higher than that of the native enzyme (EM=213−5 mV). M150G has a lower catalytic activity (kcat=133−6 s−1) than the wild-type nitrite reductase (kcat=416−10−s 1). The binding of external ligands to M150G restores spectral properties, reduction potential (EM<225 mV), and catalytic activity (kcat=374−28 s−1). Also the M150H (A460/A600=7.7, EM=104−5 mV, kcat=0.099−0.006 s−1) and M150T (A460/A600=0.085, EM=340−5 mV, kcat=126−2 s−1) variants were characterized to compare their properties with those of M150G. Crystal structures show that the ligands act as allosteric effectors by displacing Met62 which moves to bind to the Cu in the position emptied by the M150G mutation. The reconstituted type-1 site has an otherwise unaltered geometry. The observation that a rearranged ligand can introduce allosteric control in a redox enzyme suggests potential for structural and functional flexibility of copper-containing redox sites.

## Claims

### Claim 1

A method of detecting redox enzyme activity in which an electron transfer enzyme derived from a wild type oxidoreductase having a type-1 copper site is contacted with a substrate for the enzyme to oxidise or reduce the substrate and the enzyme activity is monitored via the activity of an oxidant or reductant, as the case may be, of the type 1 copper site, characterised in that the type 1 copper site has been modified compared to the wild type enzyme by substitution of a copper coordinating residue which coordinates the copper ion of the type 1 site by a residue selected from Gly and Ala, and the enzymatic reaction is carried out in the presence of an allosteric effector, which is a solute molecule which is capable of modifying the activity of the enzyme to allow an electron donating residue of the enzyme to coordinate with the copper ion of the type 1 copper site.

### Claim 2 (depends on 1)

The method according to claim 1 in which the enzyme activity is monitored by measuring the current or resistance with electron transfer from the protein to and from electrodes.

### Claim 3 (depends on 2)

The method according to claim 2 in which the electron transfer is direct from the protein to an electrode.

### Claim 4 (depends on 2)

The method according to claim 2 in which the electron transfer is via a mediator between the protein and the electrode.

### Claim 5 (depends on 1)

The method according to claim 1 in which the oxidoreductase is a dissimilatory nitrite reductase.

### Claim 6 (depends on 1)

The method according to claim 1 in which the oxidoreductase is an oxidase selected from laccase, ascorbate oxidase, ceruloplasmin and Fet3p.

### Claim 7 (depends on 5)

The method according to claim 5 in which the nitrite reductase is NiR from A. faecalis S-6.

### Claim 8 (depends on 7)

The method according to claim 7 in which the protein has the 150 Met residue replaced by Gly.

### Claim 9 (depends on 7)

The method according to claim 7 in which the substrate is pseudoazurin.

### Claim 10 (depends on 1)

The method according to claim 1 in which the solute molecule is selected from metabolites, cholesterol, drugs, hormones, sugars, fatty acids, peptides, alcohols, imidazoles, acetamide and dialkylsulphides.

### Claim 11

A redox enzyme comprising at least one copper ion and comprising sequence ID1 in which one of the residues His95, Cys136 and Met150 is substituted by a residue selected from Gly and Ala and in which the other of such residues is conserved, in which Met62 is conserved, and in which the remaining residues are identical or up to 50% of them may be conservatively substituted, and/or in which up to 10 residues at the C and/or N terminal of the SEQ ID NO:1 are deleted.

### Claim 12 (depends on 11)

The redox enzyme according to claim 11 in which no more than 25%, of the remaining residues are conservatively substituted.

### Claim 13 (depends on 11)

The redox enzyme according to claim 11 having SEQ ID NO:2.

### Claim 14 (depends on 11)

A nucleic acid encoding the enzyme of claim 11.

### Claim 15 (depends on 14)

The nucleic acid according to claim 14 which is dsDNA inserted into a plasmid vector.

### Claim 16 (depends on 14)

A microorganism comprising the nucleic acid defined in claim 14.

### Claim 17 (depends on 14)

The nucleic acid according to claim 14 having SEQ ID NO:3.

### Claim 18

A sensor comprising an electrode and, in contact with the electrode, a reaction medium containing:
i) an electron transfer enzyme derived from a wild-type oxidoreductase having a type 1 copper site, that has been modified as compared to the wild-type enzyme by substitution of a copper coordinating residue which coordinates the copper ion of the type 1 copper site by a residue selected from Gly and Ala;
ii) a substrate for the electron transfer protein; and
iii) a solute molecule, or a sample suspected of containing the solute molecule, that is capable as an allosteric effector of modifying the activity of the enzyme to allow an electron donating residue of the electron transfer enzyme to coordinate the copper ion of the type 1 copper site.

### Claim 19 (depends on 18)

The sensor according to claim 18 in which the reaction medium further contains a redox mediator.

### Claim 20 (depends on 18)

The sensor according to claim 18 in which the electron transfer enzyme is covalently bonded to the electrode.

### Claim 21 (depends on 18)

The sensor according to claim 18 which comprises an electrical current comprising current sensing and recording means.

### Claim 22 (depends on 18)

The sensor according to claim 18 which comprises several electrodes, each in contact with separate aliquots of the reaction medium, in which the electron transfer enzymes associated with separate electrodes differ from one another in their binding sites for allosteric effectors.

### Claim 23 (depends on 22)

The sensor according to claim 22 in which the separate aliquots each contain the same sample suspected of containing a solute molecule, whereby a profile of enzyme activity is determined to identify the solute.

### Claim 24

(canceled)

### Claim 25 (depends on 18)

The sensor according to claim 18 in which the substrate is nitrite.

### Claim 26 (depends on 18)

The sensor according to claim 18 in which the solute molecule is selected from metabolites, cholesterol, drugs, hormones, sugars, fatty acids, peptides, alcohols, imidazoles, acetamide and dialkylsulphides.

### Claim 27 (depends on 18)

An apparatus comprising a sensor according to claim 18, a counter electrode, an electrical circuit connected to the electrodes and current voltage or resistance measuring device in the circuit.
